"Navigating the Modern News Zoo so you don't have to."
Thursday, February 6, 2025
RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient stratification and treatment selection in metastatic prostate cancer (mPC).
👉 Full Story
Statins only add 3 DAYS to your life?!?
- The Innovative Approach to Track Small Space Debris - Arya Chandran
- Shocking: Orry’s Hilarious Birthday Video Exposes Celebrities Who Totally Ignored Him! - Aaradhana Chaurasia
- Trump Announces Military to California, Uses Emergency Powers to ‘Turn on the Water’ from Pacific Northwest - MeighTimbol
- Seizing Opportunities in the Age of AI: A Strategic Blueprint - Michael Terry
- Surgery complication up for seronegative recipients of Epstein-Barr virus-seropositive donor kidneys
- '90s Nicolas Cage Dark R-Rated Classic On Max Is Perfect Portrait Of Self-Destruction - Robert Scucci
The FAA REFUSED To Hire Qualified Whites
- Stripe makes $1.1B crypto bet as it closes on Bridge acquisition - Mary Ann Azevedo
- It’s remarkably easy to inject new medical misinformation into LLMs - John Timmer
- Has Legal Cannabis Led to Surge in Schizophrenia?
- Microsoft Ignite 2023: Unveiling the Future of AI Transformation and Technological Revolution - Sean George
- Around 100,000 eggs stolen from farm, worth tens of thousands
- The Ultimate Guide to AI Predictions - seo
